IndexIQ Advisors’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

IndexIQ Advisors’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-274,367	Closed	-$13.2M	–	1107
2020 Q1	$13.2M	Sell	274,367 -12,999	-5%	-$605K	0.61%	44
2019 Q4	$13.5M	Buy	+287,366	New	+$12.7M	0.48%	48

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

IndexIQ Advisors's RARX Position: Q2 2020 in Review

IndexIQ Advisors sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 274,367 shares — an estimated $13.2M sold.

IndexIQ Advisors first reported a position in RARX in Q4 2019 and held it in 2 quarters. The position peaked at $13.5M in Q4 2019. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

IndexIQ Advisors reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
IndexIQ Advisors sold 274,367 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $13.2M.
IndexIQ Advisors first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 2 quarters.
IndexIQ Advisors's Ra Pharmaceuticals, Inc. Common Stock position peaked at $13.5M in Q4 2019.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on IndexIQ Advisors's 13F filing for Q2 2020, filed 7 Aug 2020.